Endothelial glycocalyx and cardiopulmonary bypass

Journal of Extra-Corporeal Technology

Volumn 49, Issue 3, 2017, Pages 174-181

  Myers, Gerard J ^a   Wegner, Julie ^b  

^a Eastern Perfusion International   (Canada)

^b NONE   (United States)

Author keywords

Cardiopulmonary bypass; CPB; Endothelial glycocalyx; Eparan; Gaseous; Glycocalyx; Hemodilution; Hyperoxia; Icroemboli; Microbubbles; Syndecan; Volume loading

Indexed keywords

POLYSACCHARIDE;

CARDIOPULMONARY BYPASS; CELL DAMAGE; CELL FUNCTION; COMPLEMENT ACTIVATION; DEGRADATION; EDEMA; EMBOLISM; ENDOTHELIAL GLYCOCALYX; GASEOUS MICROEMBOLUS; GLYCOCALYX; HOMEOSTASIS; HUMAN; HYPEROXIA; HYPERVOLEMIA; INFLAMMATION; INFORMATION RETRIEVAL; MECHANOTRANSDUCTION; MEMBRANE STRUCTURE; MICROBUBBLE; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION INJURY; REVIEW; ANIMAL; MECHANICAL STRESS; METABOLISM; PROCEDURES; SHEAR STRENGTH; VASCULAR ENDOTHELIUM;

ANIMALS; CARDIOPULMONARY BYPASS; ENDOTHELIUM, VASCULAR; GLYCOCALYX; HUMANS; MECHANOTRANSDUCTION, CELLULAR; SHEAR STRENGTH; STRESS, MECHANICAL;

EID: 85041899441     PISSN: None     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol. 1896;19:312-26.
2. Weinbaum S, Tarbell J, Damiano E. The structure and function of the endothelial glycocalyx layer. Ann Rev Biomed Eng (NY). 2007;9: 121-67.
3. Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflugers Arch. 2000;440:653-66.
4. Danielli JF. Capillary permeability and edema in the perfused frog. J Cell Physiol. 1940;98:109-29.
5. Chambers R, Zweifach BW. Intercellular cement of capillary permeability. Physiol Rev. 1947;27:436-63.
6. Luft JH. Fine structures of capillary and end capillary layer as revealed by ruthenium red. Fed Proc. 1966;25:1773-83.
7. Reitsma S, Slaff DW, Vink H, et al. The endothelial glycocalyx: Composition, function and visualization. Eur J Physiol. 2007;454: 345-59.
8. Weinbaum S. Models to solve mysteries in biomechanics at the cellular level; a new view of fiber matrix layers. Ann Biomed Eng. 1998;26: 627-43.
9. Michel CC. Fluid exchange in the microcirculation -starling: The formulation of his hypothesis of microvascular fluid exchange and its significance after 100 years. Exp Physiol. 1997;82:1-30.
10. Rehm M, Zahler S, Lotsch M, et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology. 2004;100:1211-23.
11. Jacob M, Bruegger D, Rehm M, et al. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology. 2006;104:1223-31.
12. Levick JR. Revision of the Starling principle: New views of tissue fluid balance. J Physiol. 2004;557:704.
13. Curry FR. Microvascular solute and water transport. Microcirculation. 2005;12:17-31.
14. Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: An improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth. 2012;108:384-94.
15. Myburgh JA. Fluid resuscitation in acute illness: Time to reappraise the basics. N Engl J Med. 2011;364:2543-4.
16. Chappell D, Jacob M, Paul O, et al. Impaired glycocalyx barrier properties and increased capillary tube hematocrit. J Physiol. 2008; 586:4585-6.
17. US National Research Council. Transforming Glycoscience: A roadmap for the future. 2012. Available at: http://dels.nas.edu/Report/Transforming-Glycoscience-Roadmap/13446.
18. Bartlett GR. Organization of red cell glycolytic enzymes; cell coat phosphorus transfer. Ann N Y Acad Sci. 1958;75:110-4.
19. Varki A. Glycan-based interactions involving vertebrate sialic-acidrecognizing proteins. Nature. 2007;446:1023-29.
20. Rehm M, Haller M, Orth V, et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% Hetastarch solutions in patients before radical hysterectomy. Anesthesiology. 2001;95:849-56.
21. Edwards MR, Mythen MG. Fluid therapy in critical illness. Extrem Physiol Med. 2014;3:16.
22. Perrin RM, Harper SJ, Bates DO. A role for endothelial glycocalyx in regulating microvascular permeability in diabetes mellitus. Cell Biochem Biophys. 2007;49:65-72.
23. Rehm M, Bruegger D, Christ F, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007;116:1896-906.
24. Nieuwdorp M, Marijn C, Mooij HL, et al. Measuring endothelial glycocalyx dimensions in humans: A potential novel tool to monitor vascular vulnerability. J Appl Physiol (1985). 2008;104:845-52.
25. Bruegger D, Jacob M, Rehm M, et al. Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am J Physiol Heart Circ Physiol. 2005;289: H1993-9.
26. Henrich M, Gruss, M, Weigand MA. Sepsis induced degradation of endothelial glycocalyx. ScientificWorldJournal. 2010;10:917-23.
27. Bai K, Wang W. Spatio-temporal development of the endothelial glycocalyx layer and its mechanical property in vitro. J R Soc Interface. 2012;9:2290-8.
28. Bruegger D, Rehm M, Jacob M, et al. Exogenous nitric oxide requires an endothelial glycocalyx to prevent post-ischemic coronary vascular leak in guinea pig hearts. Crit Care. 2008;12:R73.
29. Gouverneur M, Spaan JA, Pannekoek H, et al. Fluid shear stress stimulates incorporation of hyaluronan into endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol. 2006;290:H458-52.
30. Schott U, Solomon C, Fries D, et al. The endothelial glycocalyx and its disruption, protection and regeneration: A narrative review. Scand J Trauma Resus Emerg Med. 2016;24.
31. Nelson A, Statkevicius S, Shott U, et al. Effects of fresh frozen plasma, Ringer's acetate and albumin on plasma volume and on circulating glycocalyx components following haemorrhagic shock in rats. Int Care Med Exp 2016;4:6.
32. Kozar RA, Peng Z, Zhang R, et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg. 2011;112:1289-95.
33. Pahakis MY, Kosky JR, Dull RO, et al. The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress. Biochem Biophys Res Commun. 2007;355:228-33.
34. Tarbell JM, Cancel LM. The glycocalyx and its significance in human medicine. J Intern Med 2016;280:97-113.
35. Weinbaum S, Zhang X, Han Y, et al. Mechanotransduction and flow across the endothelial glycocalyx. Proc Natl Acad Sci USA. 2003;100: 7988-95.
36. Keller MW, Geddes L, Spotnitz W, et al. Microcirculatory dysfunction following perfusion with hyperkalemic, hypothermic, cardioplegic solutions and blood reperfusion. Circulation. 1991;84: 2485-94.
37. Potter DR, Jiang J, Damiano ER. The recovery time course of the endothelial cell glycocalyx in vivo and its implications in vitro. Circ Res. 2009;104:1318-25.
38. Boer C, Koning NJ, Van Teeffelen J, et al. Changes in microcirculatory perfusion during cardiac surgery are paralleled by alterations in glycocalyx integrity. Crit Care. 2013;17(Suppl 2):P212.
39. Shires T, Williams J, et al. Acute change in extracellular fluids associated with major surgical procedures. Ann Surg. 1961;154:803-10.
40. McIlroy DR, Kharasch ED. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg. 2003;96:1572-7.
41. Strunden M, Heckle K, Goetz AE, et al. Perioperative fluid and volume management: Physiological basis, tools and strategies. Ann Intensive Care. 2011;1:2-8.
42. Huxley VH, Scallan J. Lymphatic fluid: Exchange mechanisms and regulation. J Physiol. 2011;589:2935-43.
43. Habib RH, Zacharias A, Schwann T, et al. Adverse effects of low hematocrit during cardiopulmonary bypass in adults: Should current practice be changed? J Thorac Cardiovasc Surg. 2003;125:1438-50.
44. Karkouti K, Djaiani G, Borger MA, et al. Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg. 2005;80:1381-7.
45. Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid management. Anesthesiology. 2008;109:723-40.
46. Selnes OA, McKhann GM, Borowicz LM, et al. Cognitive and neurobehavioral dysfunction after cardiac bypass procedures. Neurol Clin. 2006;24:133-45.
47. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395-402.
48. Stump DA. Embolic factors associated with cardiac surgery. Semin Cardiothorac Vasc Anesth. 2005;9:151-2.
49. Barak M, Nakhoul F, Katz Y, et al. Pathophysiology and clinical implications of microbubbles during hemodialysis. Semin Dial. 2008; 21:232-8.
50. Eckmann D, Armstead S. Influence of endothelial glycocalyx degradation and surfactants on air embolism adhesion. Anesthesiology. 2006;105: 1220-7.
51. Ohkuda K, Nakahara K, Binder A, et al. Venous air embolism in sheep: Reversible increase in lung microvascular permeability. J Appl Phys. 1981;51:887-94.
52. Thorsen T, Klausen H, Lie RT, et al. Bubble induced aggregation of platelets: Effects of gas species, proteins and decompression. Undersea Hyperb Med. 1993;20:101-19.
53. Malik AB, Johnson A, Tahamont MV. Mechanisms of lung vascular injury after intravascular coagulation. Ann N Y Acad Sci. 1982;384: 213-34.
54. Lee WH, Hairston P. Structure effects on blood proteins at the gasblood interface. Fed Proc. 1971;30:1615-20.
55. Ward CA, Koheil A, McCullough D, et al. Activation of complement at plasma-air or serum-air interface of rabbits. J Appl Physiol. 1986;60: 1651-8.
56. Ritz-Timme S, Eckelt N, Schmidtke E, et al. Genesis and diagnostic value of leukocyte and platelet accumulations around "air bubbles" in blood after venous air embolism. Int J Legal Med. 1998;111:22-6.
57. Sobolewski P, Kandel J, Eckmann DM. Air bubble contact with endothelial cells causes a calcium independent loss of mitochondrial membrane potential. PLoS One. 2012;7:1-8:e4725.
58. Kobayashi S, Crooks S, Eckmann DM. In vitro surfactant mitigation of gas bubble contact-induced endothelial cell death. Undersea Hyperb Med. 2011;38:27-39.
59. Stump DA. Deformable emboli and inflammation: Temporary or permanent damage. J Extra Corpor Technol. 2007;39:289-90.
60. Young RW. Hyperoxia: A review of the risks and benefits in adult cardiac surgery. J Extra Corpor Technol. 2012;44:241-9.
61. Kagawa H, Morita K, Uno Y, et al. Inflammatory response to hyperoxemic and normoxemic cardiopulmonary bypass in acyanotic pediatric patients. World J Pediatr Congenit Heart Surg. 2014;5: 541-5.
62. Ihnken K, Morita K, Buckberg GD, et al. Reduced oxygen tension during cardiopulmonary bypass limits myocardial damage in acute hypoxic immature piglet hearts. Eur J Cardiothorac Surg. 1996;10: 1127-35.
63. Fujii Y, Shirai M, Tsuchimochi H, et al. Hyperoxic condition promotes an inflammatory response during cardiopulmonary bypass in a rat model. Artif Organs. 2013;37:1034-40.
64. Bulutcu FS, Bayindir O, Polat B, et al. Does normoxemic cardiopulmonary bypass prevent myocardial reoxygenation injury in cyanotic children?. J Cardiothorac Vasc Anesth. 2002;16:330-3.
65. Joachimsson PO, Sjoberg F, Forsman M, et al. Adverse effects of hyperoxemia during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;112:812-19.
66. Singh A, Ramnath RD, Foster RR, et al. Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx. PLoS One. 2013;8:e55852.
67. Rops AL, van der Vlag J, Lensen JF, et al. Heparan sulfate proteoglycans in glomerular inflammation. Kidney Int. 2004;65:768-85.
68. Moseley R, Waddington R, Evans P, et al. The chemical modification of glycosaminoglycan structure by oxygen-derived species in vitro. Biochim Biophys Acta. 1995;1244:245-52.
69. Granger DN. Ischemia-reperfusion: Mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation. 1999;6:167-78.
70. Lindner JR, Ismail S, Spotnitz WD, et al. Albumin microbubble persistence during myocardial contrast echocardiography is associated with microvascular endothelial glycocalyx damage. Circulation 1998; 98:2187-94.
71. Anttonen A, Leppa S, Ruotsalainen T, et al. Pretreatment serum syndecan-1 levels and outcome in small cell lung cancer patients treated with platinum based chemotherapy. Lung Cancer. 2003;41:171-7.
72. Peters L, Mocroft A, Soriano V, et al. Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis co-infected patients. PLoS One. 2013;8:e64283.
73. Chappell D, Bruegger D, Potzel J, et al. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care. 2014;18:538.
74. Johansson PI, Stensballe J, Rasmussen LS, et al. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254:194-200.
75. Rahbar E, Cardenas J, Baimukanova G, et al. Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients. J Transl Med. 2015;13:117.
76. Filho T, Torres LN, Salgado C, et al. Plasma syndecan-1 and heparan sulfate correlate with microvascular glycocalyx degradation in hemorrhaged rats after different resuscitation fluids. Am J Physiol Heart Circ Physiol. 2016;310:H1468-78.
77. Jacob M, Paul O, Mehringer L, et al. Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation. 2009;87:956-65.
78. Becker B, Chappell D, Bruegger D, et al. Therapeutic strategies targeting the endothelial glycocalyx: Acute deficits but great potential. Cardiovasc Res. 2010;87:300-10.
79. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit (SAFE Study). N Engl J Med. 2004;350:2247.
80. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2009;3:CD000567.
81. Roberts I, Blackhall K, Alderson P, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2011;11:CD001208.
82. Myburgh JA, Finer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care (CHEST Study). N Engl JMed. 2012;367:1901-11.
83. Hartog C, Reinhart K. Hydroxyethyl starch solutions are unsafe in critically ill patients. Int Care Med. 2009;35:1337-42.
84. Perner A, Haase N, Guttormsen A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis (6S Trial). N Engl JMed. 2012; 367:124-34.